Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

EPA & Chevron Reach Agreement in Navajo Nation Uranium Contamination Probeý

Demand for Diamonds Wanes in India

Anglo Pacific Acquires Iron Ore Royalty via Greenland Investment

Stillwater Mining Posts Record Profits

New Pacific Metals Releases Assay Results from Tagish Lake Property

Zone Resources Completes Airborne Survey at Labrador Trough

Marathon Oil Norge Completes Drilling of Wildcat Well

Pershimco Resources Reports Further Assay Results from Cerro Quema Project

Galahad Metals Completes Surface Geophysical Survey at Regcourt Gold Project

Fancamp Exploration Elated With Metallurgy Test Results of Magpie Mines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.